Clinical Trial: Candida Host Defense Response After Septic Shock in the Critically Ill

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: IMMUNOCANDIDA Candida Host Defense Response After Septic Shock in the Critically Ill

Brief Summary: Septic shock is associated with acquired immunoparalysis which is associated with a high risk of nosocomial acquired infection. Nosocomial candidiasis is associated with a 50% rate of mortality but is difficult to diagnose. The use of colonization indexes and risk factors on the other hand expose to unnecessary use of antifungals. The aim of the present study is to evaluate whether the host response to infection associated with candida biomarkers would help to anticipate the candidiasis onset.